This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ pyrimethamine,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Antimalarial Properties: Pyrimethamine is effective against the malaria parasite Plasmodium falciparum, which causes the most severe form of malaria. It works by inhibiting the enzyme dihydrofolate reductase (DHFR) in the parasite, thereby disrupting its ability to synthesize DNA and replicate.

  2. Treatment of Malaria: Pyrimethamine is often used in combination with other antimalarial drugs, such as sulfadoxine or chlorproguanil, to treat uncomplicated malaria infections. It is also used in combination with sulfadoxine as a preventive treatment for malaria in certain regions where drug resistance is not widespread.

  3. Toxoplasmosis Treatment: Pyrimethamine is also used for the treatment of toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. It is particularly important in individuals with weakened immune systems, such as those with HIV/AIDS, to prevent severe complications of toxoplasmosis.

  4. Prevention of Congenital Toxoplasmosis: Pyrimethamine may be used in pregnant women to prevent the transmission of toxoplasmosis to the fetus and reduce the risk of congenital toxoplasmosis. It is often used in combination with sulfadiazine and folinic acid in this setting.

  5. Side Effects: Common side effects of pyrimethamine may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain. It may also cause headache, dizziness, rash, and elevated liver enzymes. These side effects are usually mild and temporary.

  6. Hematologic Effects: Pyrimethamine can suppress the bone marrow's production of blood cells, leading to hematologic side effects such as leukopenia (reduced white blood cell count), thrombocytopenia (reduced platelet count), and megaloblastic anemia (due to folate deficiency).

  7. Folic Acid Supplementation: Pyrimethamine inhibits the action of dihydrofolate reductase, which can lead to folate deficiency. To mitigate this risk, folinic acid (also known as leucovorin) is often prescribed alongside pyrimethamine to prevent or treat folate deficiency and its associated side effects.

  8. Allergic Reactions: Some individuals may experience allergic reactions to pyrimethamine, which can manifest as rash, itching, swelling, or difficulty breathing. Severe allergic reactions such as anaphylaxis are rare but possible.

  9. Drug Interactions: Pyrimethamine may interact with other medications, including antifolate drugs such as methotrexate, increasing the risk of hematologic toxicity. It may also interact with anticonvulsant medications, leading to reduced effectiveness or increased side effects.

  10. Pregnancy and Lactation: Pyrimethamine should be used with caution during pregnancy, especially during the first trimester, as it may pose risks to the developing fetus. It may also be excreted in breast milk, so breastfeeding women should consult their healthcare providers before taking pyrimethamine.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of pyrimethamine,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Anaerobutyricum hallii Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium bifidum Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium catenulatum Reduces
species Bifidobacterium longum Reduces
species Christensenella minuta Reduces
species Escherichia coli Reduces
species Faecalibacterium prausnitzii Reduces
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces
species Veillonella atypica Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by pyrimethamine,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Bifidobacterium genus Decreases
0 1 Veillonella genus Decreases
0 1 Odoribacter genus Decreases
0 1 Thomasclavelia genus Decreases
0 1 Bacteroides genus Decreases
0 1 Streptococcus genus Decreases
0 1 Lacticaseibacillus genus Decreases
1 0 Akkermansia genus Decreases
0 1 Phocaeicola genus Decreases
0 1 Agathobacter genus Decreases
0 1 Eggerthella genus Decreases
0 1 Enterocloster genus Decreases
0 1 Clostridium genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Coprococcus genus Decreases
0 1 Lachnospira genus Decreases
0 1 Roseburia genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Clostridioides genus Decreases
0 1 Collinsella genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Escherichia genus Decreases
0 1 Segatella genus Decreases
0 1 Flavonifractor genus Decreases
0 1 Coprobacter genus Decreases
0 1 Shigella genus Decreases
0 1 Dorea genus Decreases
0 1 Gemella genus Decreases
0 1 Butyricimonas genus Decreases
0 1 Blautia genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Coprococcus comes species Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Bacteroides caccae species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Eggerthella lenta species Decreases
1 0 Enterocloster bolteae species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Parabacteroides distasonis species Decreases
1 0 Phocaeicola vulgatus species Decreases
1 0 Streptococcus parasanguinis species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Veillonella parvula species Decreases
1 0 Lachnospira eligens species Decreases
1 0 Roseburia intestinalis species Decreases
1 0 Parabacteroides merdae species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Roseburia hominis species Decreases
1 0 Collinsella aerofaciens species Decreases
0 1 Streptococcus sp. HSISM1 species Decreases
0 1 Streptococcus sp. LPB0220 species Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Escherichia coli species Decreases
1 0 Segatella copri species Decreases
0 1 Veillonella rodentium species Decreases
0 1 Veillonella dispar species Decreases
0 1 Eggerthella guodeyinii species Decreases
0 1 Bacteroides sp. CACC 737 species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Bifidobacterium breve species Decreases
1 0 Dorea formicigenerans species Decreases
0 1 Streptococcus lactarius species Decreases
0 1 Veillonella sp. S12025-13 species Decreases
0 1 Bifidobacterium angulatum species Decreases
0 1 Veillonella nakazawae species Decreases
1 0 Blautia obeum species Decreases
0 1 Streptococcus salivarius species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Veillonella rogosae species Decreases
0 1 Bacteroides humanifaecis species Decreases
0 1 Streptococcus sp. FDAARGOS_192 species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Streptococcus australis species Decreases
0 1 Bacteroides sp. A1C1 species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
0 1 Flavonifractor plautii species Decreases
0 1 Shigella flexneri species Decreases
0 1 Streptococcus infantis species Decreases
0 1 Escherichia albertii species Decreases
0 1 Streptococcus sp. oral taxon 061 species Decreases
0 1 Parolsenella catena species Decreases
0 1 Bacteroides sp. M10 species Decreases
0 1 Bacteroides sp. HF-162 species Decreases
0 1 Blautia parvula species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Coprococcus catus species Decreases
0 1 Streptococcus oralis species Decreases
0 1 Bacteroides faecium species Decreases
0 1 Blautia argi species Decreases
0 1 Veillonella atypica species Decreases
0 1 Dorea longicatena species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Alistipes megaguti species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Streptococcus vestibularis species Decreases
0 1 Parolsenella massiliensis species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Bifidobacterium catenulatum species Decreases
0 1 Streptococcus sp. oral taxon 431 species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Streptococcus ilei species Decreases
0 1 Segatella bryantii species Decreases
0 1 Bacteroides caecimuris species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Coprobacter fastidiosus species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Hungatella hathewayi species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Collinsella stercoris species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 Lacrimispora saccharolytica species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Shigella boydii species Decreases
0 1 Streptococcus sp. Marseille-Q6470 species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 uncultured Alistipes sp. species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Streptococcus gordonii species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Barnesiella viscericola species Decreases
0 1 Alistipes onderdonkii species Decreases
0 1 Butyricimonas virosa species Decreases
1 0 Fusobacterium nucleatum species Decreases
0 1 Bifidobacterium bifidum species Decreases
0 1 Enterocloster clostridioformis species Decreases
0 1 Alistipes sp. dk3624 species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Alistipes senegalensis species Decreases
0 1 Blautia liquoris species Decreases
0 1 Coprobacter secundus species Decreases
0 1 Simiaoa sunii species Decreases
0 1 Christensenella minuta species Decreases
0 1 Alistipes finegoldii species Decreases
0 1 Anaerostipes caccae species Decreases
0 1 Faecalibacterium sp. I4-1-79 species Decreases
0 1 Alistipes shahii species Decreases
0 1 Ruminococcus champanellensis species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Leyella stercorea species Decreases
0 1 Faecalibacterium sp. I2-3-92 species Decreases
0 1 Streptococcus sp. A12 species Decreases
0 1 Faecalibacterium sp. HTF-F species Decreases
0 1 Alistipes dispar species Decreases
0 1 Faecalibacterium sp. IP-3-29 species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 Alistipes communis species Decreases
0 1 Bacteroides nordii species Decreases
0 1 Catenibacterium sp. co_0103 species Decreases
0 1 Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases
0 1 Faecalibacterium sp. I3-3-89 species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Faecalibacterium prausnitzii species Decreases
0 1 Marvinbryantia formatexigens species Decreases
1 0 [Ruminococcus] torques species Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases

Impact of pyrimethamine,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.6 0.6
Acne 0.5 -0.5
ADHD 5.3 1.1 3.82
Age-Related Macular Degeneration and Glaucoma 0.5 0.4 0.25
Allergic Rhinitis (Hay Fever) 3.4 3.9 -0.15
Allergies 6.7 4.2 0.6
Allergy to milk products 2.6 1.7 0.53
Alopecia (Hair Loss) 1 0.2 4
Alzheimer's disease 6.6 7.9 -0.2
Amyotrophic lateral sclerosis (ALS) Motor Neuron 4.1 1.1 2.73
Ankylosing spondylitis 5.1 1.6 2.19
Anorexia Nervosa 2.1 3.9 -0.86
Antiphospholipid syndrome (APS) 2 0.1 19
Asthma 6.2 4.1 0.51
Atherosclerosis 2.5 2.3 0.09
Atrial fibrillation 4.6 2.6 0.77
Autism 11.6 11.2 0.04
Autoimmune Disease 1.3 1.2 0.08
Barrett esophagus cancer 0.6 0.5 0.2
benign prostatic hyperplasia 0.3 0.5 -0.67
Biofilm 2.8 2.8
Bipolar Disorder 2.6 1.8 0.44
Brain Trauma 1.2 1.5 -0.25
Breast Cancer 0.5 0.5
Cancer (General) 1.1 3.3 -2
Carcinoma 3.8 2.5 0.52
Celiac Disease 4.6 4.3 0.07
Cerebral Palsy 2.9 1 1.9
Chronic Fatigue Syndrome 8 7.2 0.11
Chronic Kidney Disease 4.6 2.7 0.7
Chronic Lyme 0.5 0.8 -0.6
Chronic Obstructive Pulmonary Disease (COPD) 2.9 2 0.45
Chronic Urticaria (Hives) 1.9 1.6 0.19
Coagulation / Micro clot triggering bacteria 1.5 1 0.5
Cognitive Function 2.4 2.2 0.09
Colorectal Cancer 8 3.4 1.35
Constipation 1.9 0.3 5.33
Coronary artery disease 2.8 3.6 -0.29
COVID-19 12.5 14.6 -0.17
Crohn's Disease 9.7 6.8 0.43
Cushing's Syndrome (hypercortisolism) 1.1 -1.1
cystic fibrosis 0.5 1.9 -2.8
d-lactic acidosis (one form of brain fog) 0.3 0.3
deep vein thrombosis 2.2 1.4 0.57
Denture Wearers Oral Shifts 1.4 1.4
Depression 14.1 11.7 0.21
Dermatomyositis 0.5 0.5 0
Eczema 2.5 2.8 -0.12
Endometriosis 3.1 2.5 0.24
Eosinophilic Esophagitis 0.1 1 -9
Epilepsy 4.5 3 0.5
erectile dysfunction 1.3 0.5 1.6
Fibromyalgia 3.7 3.1 0.19
Functional constipation / chronic idiopathic constipation 7.2 4.6 0.57
gallstone disease (gsd) 3.4 1.3 1.62
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 2 1.3 0.54
Generalized anxiety disorder 3.7 3.3 0.12
giant cell arteritis 0.4 -0.4
Glioblastoma 0.5 -0.5
Gout 2.9 1.4 1.07
Graves' disease 2.3 3.1 -0.35
Gulf War Syndrome 1.3 2.8 -1.15
Halitosis 1.7 0.6 1.83
Hashimoto's thyroiditis 3.6 2 0.8
Heart Failure 4.9 2.4 1.04
hemorrhagic stroke 0.5 0.5
Hidradenitis Suppurativa 1.3 0.5 1.6
High Histamine/low DAO 1.6 0.8 1
hypercholesterolemia (High Cholesterol) 1.3 0.6 1.17
hyperglycemia 1.8 2.7 -0.5
Hyperlipidemia (High Blood Fats) 1.2 0.2 5
hypersomnia 0.2 0.3 -0.5
hypertension (High Blood Pressure 4.7 7.3 -0.55
Hypothyroidism 0.7 1.4 -1
Hypoxia 3.1 3.1
IgA nephropathy (IgAN) 2.1 6 -1.86
Inflammatory Bowel Disease 11.1 11.3 -0.02
Insomnia 2.3 4.3 -0.87
Intelligence 2.4 0.4 5
Intracranial aneurysms 1.2 0.7 0.71
Irritable Bowel Syndrome 7.9 7.3 0.08
ischemic stroke 3.6 1.7 1.12
Liver Cirrhosis 8.2 5.4 0.52
Long COVID 10.4 8.3 0.25
Low bone mineral density 1 -1
Lung Cancer 0.9 1.4 -0.56
Lymphoma 0.3 0.1 2
Mast Cell Issues / mastitis 0.9 1 -0.11
ME/CFS with IBS 1.6 2.6 -0.63
ME/CFS without IBS 2.8 2.1 0.33
membranous nephropathy 0.5 0.5
Menopause 2.7 0.8 2.38
Metabolic Syndrome 8.6 9.8 -0.14
Mood Disorders 14.7 10.2 0.44
multiple chemical sensitivity [MCS] 1.7 0.2 7.5
Multiple Sclerosis 8.1 7 0.16
Multiple system atrophy (MSA) 2.3 0.8 1.87
myasthenia gravis 0.8 0.7 0.14
neuropathic pain 0.5 3.4 -5.8
Neuropathy (all types) 1.6 1.6 0
neuropsychiatric disorders (PANDAS, PANS) 1.3 0.1 12
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 5.5 6.1 -0.11
NonCeliac Gluten Sensitivity 2.4 1 1.4
Obesity 11 9.9 0.11
obsessive-compulsive disorder 6.4 4.6 0.39
Osteoarthritis 3.7 2.4 0.54
Osteoporosis 2.7 2 0.35
pancreatic cancer 1.1 0.5 1.2
Parkinson's Disease 9.3 7.5 0.24
Polycystic ovary syndrome 7.1 3.9 0.82
Postural orthostatic tachycardia syndrome 0.4 1 -1.5
Premenstrual dysphoric disorder 0.8 0.4 1
primary biliary cholangitis 1.1 1.8 -0.64
Primary sclerosing cholangitis 3.8 3 0.27
Psoriasis 4.3 3.6 0.19
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 7.4 4.9 0.51
Rosacea 0.9 0.8 0.13
Schizophrenia 9 3.9 1.31
scoliosis 0.8 0.8 0
sensorineural hearing loss 0.1 0.1
Sjögren syndrome 3.4 3.4 0
Sleep Apnea 1.5 1.7 -0.13
Slow gastric motility / Gastroparesis 1.5 0.5 2
Small Intestinal Bacterial Overgrowth (SIBO) 2.7 0.6 3.5
Stress / posttraumatic stress disorder 3.1 3.5 -0.13
Systemic Lupus Erythematosus 5.4 2.1 1.57
Tic Disorder 1.8 1.5 0.2
Tourette syndrome 1.1 0.5 1.2
Type 1 Diabetes 5.2 5 0.04
Type 2 Diabetes 10.5 9.3 0.13
Ulcerative colitis 7.4 9 -0.22
Unhealthy Ageing 5.7 3.2 0.78
Vitiligo 2.9 2.5 0.16

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]